Clinical Trial: Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase II, Double Blind, Placebo-controlled, Randominzed, Multi-Center, Parallel Group Study to Evaluate the Efficacy and Safety of T89 in Patient With Chronic Stable Angina Pec

Brief Summary: The purpose of this study is to determine the anti-angina effect and dose response of T89, a 2-herb botanical drug product, in patients with chronic stable angina pectoris in the United States.